Mitesco (MITI) Amortization of Deferred Charges (2011 - 2026)
Mitesco (MITI) reported Amortization of Deferred Charges of $9127.0 for Q1 2026, down 98.39% on a QoQ basis from $565431.0 in Q1 2022.
Mitesco (MITI) has 5 years of Amortization of Deferred Charges data on file, last reported at $9127.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges changed N/A year-over-year to $9127.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9127.0 (changed N/A YoY) and the FY2022 annual result came in at $565431.0, changed N/A from the prior year.
- Amortization of Deferred Charges slipped to $9127.0 in Q1 2026 per MITI's latest filing, from $565431.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $565431.0 in Q1 2022 and bottomed at $9127.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Mitesco | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,127.00 |
| Mar 31, 2026 | 9,127.00 |
| Mar 31, 2022 | 565,431.00 |
| Mar 31, 2022 | 565,431.00 |
| Dec 31, 2020 | -6,983.00 |
| Dec 31, 2020 | -6,983.00 |
| Dec 31, 2019 | -26,330.00 |
| Dec 31, 2019 | -26,330.00 |
| Sep 30, 2011 | 189.00 |
| Sep 30, 2011 | 189.00 |